ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 67

Increased Prevalence of Hypothyroidism Preceding Rheumatoid Arthritis – an Epidemiological Study

Anne M. Kerola1, Tuomo Nieminen2, Markku J. Kauppi3, Hannu Kautiainen4, Kari Puolakka5, Lauri J. Virta6 and Tuomas Kerola3, 1Medical School, University of Helsinki, Helsinki, Finland, 2Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland, 3Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland, 4Unit of Primary Health Care, Kuopio University Hospital, Kuopio, Finland, 5Department of Medicine, South Karelia Central Hospital, Lappeenranta, Finland, 6Research Department, the Social Insurance Institution, Turku, Finland

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Comorbidity, rheumatoid arthritis (RA) and thyroid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research: Epidemiology and Outcomes of Rheumatic Disease I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid arthritis (RA) is associated with a wide set of comorbidities, including several autoimmune diseases such as autoimmune thyroiditis, which is a common cause of hypothyroidism. Whether the prevalence of hypothyroidism is elevated during the preclinical phase of RA when several autoimmune processes are already activated is not yet known. The aim of the study was to compare the prevalence of hypothyroidism among RA patients and non-RA-subjects at the time of RA diagnosis, and to determine whether the risk of hypothyroidism varies by age at the onset of RA, or by sex or rheumatoid factor (RF) status.

Methods: We identified 7,209 incident RA patients diagnosed between January 2004 and December 2007 from a Finnish nationwide register of special reimbursements for medication costs. The presence of hypothyroidism was identified from the same register based on special reimbursement decisions for thyroxine substitution. The prevalence of hypothyroidism at the onset of RA was compared to that of an age- and sex-matched Finnish population, and a standardized rate ratio (SRR) for hypothyroidism was calculated.

Results: The SRR for hypothyroidism preceding RA was 1.51; 95% confidence interval (CI): 1.35–1.67. The SRR was highest among younger RA patients, the excess prevalence of hypothyroidism decreasing steadily and wearing off among patients who were older at the time of diagnosis (Figure). The SRR for hypothyroidism was almost 2.5 among women between 20 and 49 years of age at RA diagnosis. The absolute prevalence of hypothyroidism, however, increased with age as it does in the general population. The SRR was similar between RF-positive and RF-negative patients: 1.46 (95% CI: 1.27–1.66) and 1.61 (95% CI: 1.34–1.91), respectively. Sex also did not modify the SRR point estimates, although the results did not reach statistical significance among men.

Conclusion:   The prevalence of hypothyroidism is already increased among RA patients at the disease onset, especially among young women. This calls for attention to screening for hypothyroidism in younger RA patients. Furthermore, the clinician should be mindful of the possibility of RA as the underlying cause of joint symptoms in young female patients with hypothyroidism.

Figure. The standardized rate ratios (SRR) of hypothyroidism according to sex and age among 7,209 RA patients at disease onset compared with their age- and sex-matched non-RA equivalents. 95% confidence intervals are shown with whiskers.

 


Disclosure:

A. M. Kerola,
None;

T. Nieminen,
None;

M. J. Kauppi,
None;

H. Kautiainen,
None;

K. Puolakka,
None;

L. J. Virta,
None;

T. Kerola,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-prevalence-of-hypothyroidism-preceding-rheumatoid-arthritis-an-epidemiological-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology